|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
2,080,000 |
Market
Cap: |
1.49(M) |
Last
Volume: |
1,523,296 |
Avg
Vol: |
1,519,157 |
52
Week Range: |
$0.714 - $0.714 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sonoma Pharmaceuticals is a global healthcare provider for developing and producing stabilized hypochlorous acid products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. Co.'s products include: Celacyn® Scar Management Gel, which provides scar management by protecting and moisturizing wound and scar sites; Microcyn® Wound Care Management, which provides improved healing properties; Acuicyn Eyelid and Eyelash Hygiene, which provides eyelid and eyelash hygiene; and Microdacyn60® Oral Care, which supports the treatment of mouth and throat infections and the debridement and moistening of mouth lesions and thrush.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Miller Robert E |
Chief Financial Officer |
|
2016-12-08 |
4 |
B |
$4.86 |
$24,300 |
I/I |
5,000 |
6,714 |
1.99 |
- |
|
Schutz James J |
Chief Executive Officer |
|
2016-12-08 |
4 |
B |
$4.88 |
$4,880 |
D/D |
1,000 |
11,040 |
2.73 |
- |
|
Northey Robert Allen |
Exec. VP of Res & Devlpment |
|
2016-11-30 |
4 |
A |
$4.81 |
$22,501 |
D/D |
4,678 |
4,678 |
|
- |
|
Schutz James J |
Chief Executive Officer |
|
2016-11-30 |
4 |
A |
$4.81 |
$17,003 |
D/D |
3,535 |
10,040 |
|
- |
|
Miller Robert E |
Chief Financial Officer |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,593 |
15,964 |
|
- |
|
Mclaughlin John |
Director |
|
2016-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,423 |
7,999 |
|
- |
|
Harrison Russell Joseph |
Director |
|
2016-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,229 |
6,917 |
|
- |
|
Birnbaum Jay E |
Director |
|
2016-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
841 |
5,722 |
|
- |
|
Barbari Sharon Surrey |
Director |
|
2016-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,035 |
6,244 |
|
- |
|
Birnbaum Jay E |
Director |
|
2016-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
974 |
4,881 |
|
- |
|
Barbari Sharon Surrey |
Director |
|
2016-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,199 |
5,209 |
|
- |
|
Mclaughlin John |
Director |
|
2016-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,648 |
6,576 |
|
- |
|
Harrison Russell Joseph |
Director |
|
2016-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,423 |
5,688 |
|
- |
|
Schutz James J |
Chief Executive Officer |
|
2016-08-15 |
4 |
B |
$3.66 |
$4,866 |
D/D |
1,328 |
6,505 |
2.73 |
- |
|
Barbari Sharon Surrey |
Director |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,445 |
20,051 |
|
- |
|
Harrison Russell Joseph |
Director |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,090 |
21,327 |
|
- |
|
Birnbaum Jay E |
Director |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,188 |
19,541 |
|
- |
|
Mclaughlin John |
Director |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,765 |
24,643 |
|
- |
|
Mclaughlin John |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,878 |
17,878 |
|
- |
|
Birnbaum Jay E |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,353 |
15,353 |
|
- |
|
Harrison Russell Joseph |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,237 |
16,237 |
|
- |
|
Barbari Sharon Surrey |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,606 |
15,606 |
|
- |
|
Schutz James J |
Chief Executive Officer |
|
2016-02-25 |
4 |
B |
$1.00 |
$5,000 |
D/D |
5,000 |
25,885 |
2.81 |
- |
|
Schutz James J |
Chief Executive Officer |
|
2014-11-17 |
4 |
B |
$1.78 |
$11,187 |
D/D |
6,285 |
20,885 |
2.81 |
- |
|
Schutz James J |
Chief Executive Officer |
|
2013-08-16 |
4 |
B |
$2.35 |
$11,985 |
D/D |
5,100 |
14,600 |
2.81 |
- |
|
115 Records found
|
|
Page 3 of 5 |
|
|